Product Description
| Brand Name |
Canmab |
| Active Ingredient |
Trastuzumab |
| Manufactured By |
Biocon Ltd. |
| Form |
Injection |
| Strength |
440 mg |
| Pack Size |
Single Vial |
Canmab injection is a medicine developed by Biocon Ltd, a reputed bio pharmaceutical company based in Bangalore, India. It contains trastuzumab that is highly effective for the treatment of HER2-positive breast cancer. It comes in the form of injection. Canmab (trastuzumab) works by reducing or preventing the spreading of cancer virus in the body and thereby helps in curing.
Common Side Effects :
- Headache
- Nausea
- Fatigue
- Rash
- Congestive cardiac failure
- Reduced blood platelets
- Insomnia (difficulty in sleeping)
- Upper respiratory tract infection
- Nasopharyngitis
- Anemia
- Fever
- Cough
- Diarrhoea
- Altered taste
- Weight loss
- Stomatitis (Inflammation of the mouth)
- Mucosal inflammation
- Decreased white blood cell count (neutrophils)
Temperature: Store at 2 C to 8 C
We are one of the acclaimed Traders and Exporters of Canmab 440 mg Injection that are hygienically prepared and packed at our vendors location. Processed making usage of top class chemicals, ingredients and futuristic machines and tackles, these presented products are widely applauded and recommended.
Other Details :
- Combipack of 1 vial of trastuzumab for injection + 2 vials of Bacteriostatic water for injection USP (diluent)
- Multi Use vial for i.v infusion lyophilised powder
Precise Treatment for HER2-Positive CancersCanmab Injection is specially formulated for the management of certain types of cancer, notably HER2-positive breast cancer. With Trastuzumab as its chief component, it targets cancer cells more specifically, helping to improve therapeutic outcomes while minimizing side effects associated with more general therapies.
Quality and Safe StorageManufactured in India and handled by experienced exporters and suppliers, Canmab maintains its stability best when stored at room temperature. Ensuring proper storage and adhering to its three-month shelf life help preserve its effectiveness for patients undergoing cancer treatment.
FAQs of Canmab injection:
Q: How is Canmab Injection administered for cancer treatment?
A: Canmab Injection is administered intravenously, typically by a healthcare professional in a clinical setting. The dosage and schedule are determined by the doctor based on the patients medical profile and the type of cancer being treated.
Q: What is the main ingredient in Canmab Injection and how does it work?
A: The primary ingredient in Canmab is Trastuzumab, a monoclonal antibody that binds to HER2-positive cancer cells. This action inhibits cell growth and promotes destruction of the cancer cells, making it effective for HER2-positive breast cancers.
Q: When should Canmab Injection be used in cancer therapy?
A: Canmab Injection should be used as prescribed by an oncologist, usually when HER2-positive cancer is confirmed. It is often given in cycles, either alone or in combination with other chemotherapy agents, depending on the treatment plan.
Q: Where should Canmab Injection be stored for optimal efficacy?
A: Canmab Injection should be kept at room temperature, away from direct sunlight, moisture, and extremes of temperature. Proper storage ensures its stability and effectiveness until the end of its three-month shelf life.
Q: What is the benefit of choosing Canmab Injection for cancer treatment?
A: Canmab Injection offers targeted therapy for patients with HER2-positive cancers, enhancing treatment effectiveness and potentially reducing the risk of cancer progression. Its use under medical guidance can improve overall patient outcomes.
Q: What is the process to purchase Canmab Injection from a wholesaler or supplier?
A: To acquire Canmab Injection, healthcare providers or pharmacies can contact authorized exporters, suppliers, or traders in India. It is important to ensure they are licensed and that the product is sourced through legitimate distribution channels.